Richert-Boe KE - Search Results

1

Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.

Glass AG, Leo MC, Haddad Z, Yousefi K, du Plessis M, Chen C, Choeurng V, Abdollah F, Robbins B, Ra S, Richert-Boe KE, Buerki C, Pearson K, Davicioni E, Weinmann S. Glass AG, et al. Among authors: richert boe ke. J Urol. 2016 Jun;195(6):1748-53. doi: 10.1016/j.juro.2015.11.044. Epub 2015 Nov 26. J Urol. 2016. PMID: 26626216

2

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.

Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J. Oster G, et al. Among authors: richert boe ke. Support Care Cancer. 2014 May;22(5):1363-73. doi: 10.1007/s00520-013-2094-y. Epub 2014 Jan 4. Support Care Cancer. 2014. PMID: 24389827

3

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.

Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J. Oster G, et al. Among authors: richert boe ke. Support Care Cancer. 2013 Dec;21(12):3279-86. doi: 10.1007/s00520-013-1887-3. Epub 2013 Jul 25. Support Care Cancer. 2013. PMID: 23884473

4

Medical history, body size, and cigarette smoking in relation to fatal prostate cancer.

Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK, Richert-Boe KE, Weiss NS. Weinmann S, et al. Among authors: richert boe ke. Cancer Causes Control. 2010 Jan;21(1):117-25. doi: 10.1007/s10552-009-9441-9. Epub 2009 Oct 9. Cancer Causes Control. 2010. PMID: 19816779

5

Racial differences in treatment of early-stage prostate cancer.

Richert-Boe KE, Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK, Weiss NS. Richert-Boe KE, et al. Urology. 2008 Jun;71(6):1172-6. doi: 10.1016/j.urology.2007.10.010. Epub 2008 Feb 15. Urology. 2008. PMID: 18279922

6

Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study.

Weinmann S, Richert-Boe KE, Van Den Eeden SK, Enger SM, Rybicki BA, Shapiro JA, Weiss NS. Weinmann S, et al. Among authors: richert boe ke. Epidemiology. 2005 May;16(3):367-76. doi: 10.1097/01.ede.0000158395.05136.02. Epidemiology. 2005. PMID: 15824554

7

The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.

Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. Doria-Rose VP, et al. Among authors: richert boe ke. Gastroenterology. 2004 Sep;127(3):714-22. doi: 10.1053/j.gastro.2004.06.048. Gastroenterology. 2004. PMID: 15362026

8

Screening digital rectal examination and prostate cancer mortality: a case-control study.

Richert-Boe KE, Humphrey LL, Glass AG, Weiss NS. Richert-Boe KE, et al. J Med Screen. 1998;5(2):99-103. doi: 10.1136/jms.5.2.99. J Med Screen. 1998. PMID: 9718529

9

Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk.

McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. McWilliams JE, et al. Among authors: richert boe ke. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):589-94. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8547824

10

Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon.

Richert-Boe KE. Richert-Boe KE. Cancer. 1995 May 15;75(10):2605-12. doi: 10.1002/1097-0142(19950515)75:10<2605::aid-cncr2820751031>3.0.co;2-#. Cancer. 1995. PMID: 7736408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters